Year: 2015
Type: article
Abstract: The development of a wide range of therapeutics based on the nitric oxide signaling pathway has been fueled by keen clinical observation followed by laboratory study and a return to the bedside in an iterative process that is continuing to yield new insights.
Source: New England Journal of Medicine
Institutions: Brigham and Women's Hospital, Harvard University
Language: English
Subfield: Physiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W973218263
